ASH 2022 | The management of post-transplant cytopenia in patients with multiple myeloma
Naresh Bumma
• 11 Dec 2022
Naresh Bumma, MD, The Ohio State University Comprehensive Cancer Center, Columbus, OH, discusses the management of post-transplant cytopenias in patients with multiple myeloma, highlighting the importance of understanding the cause and severity of the cytopenia to select the appropriate management strategy. This interview took place at the 64th ASH Annual Meeting and Exposition congress in New Orleans, LA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Disclosures
Janssen: Membership on an entity’s Board of Directors or advisory committees, Other: Ad Board; Sanofi, Genzyme: Other: Ad Board, Speakers Bureau; Amgen: Consultancy, Speakers Bureau.
